CANCER_TYPE,Measure_Names,STANDARD,Avg_PERFORMANCE,TOTAL_TREATED
Suspected acute leukaemia,Avg. PERFORMANCE,2WW,0.962174941,183
Suspected brain/central nervous system tumours,Avg. PERFORMANCE,2WW,0.950691788,10055
Suspected breast cancer,Avg. PERFORMANCE,2WW,0.942574039,331304
Suspected children's cancer,Avg. PERFORMANCE,2WW,0.9543458,9361
Suspected gynaecological cancer,Avg. PERFORMANCE,2WW,0.953094997,170587
Suspected haematological malignancies (excluding acute leukaemia),Avg. PERFORMANCE,2WW,0.960721769,17775
Suspected head & neck cancer,Avg. PERFORMANCE,2WW,0.952021689,176945
Suspected lower gastrointestinal cancer,Avg. PERFORMANCE,2WW,0.924925216,301455
Suspected lung cancer,Avg. PERFORMANCE,2WW,0.960406586,64451
Suspected other cancer,Avg. PERFORMANCE,2WW,0.948847496,2018
Suspected sarcoma,Avg. PERFORMANCE,2WW,0.941009995,10377
Suspected skin cancer,Avg. PERFORMANCE,2WW,0.929837122,371805
Suspected testicular cancer,Avg. PERFORMANCE,2WW,0.972886443,10429
Suspected upper gastrointestinal cancer,Avg. PERFORMANCE,2WW,0.924606541,189503
Suspected urological malignancies (excluding testicular),Avg. PERFORMANCE,2WW,0.943454075,201055
Exhibited (non-cancer) breast symptoms - cancer not initially suspected,Avg. PERFORMANCE,2WW Breast,0.92381584,209776
ALL CANCERS,Avg. PERFORMANCE,31 Days,0.978897299,284149
Breast,Avg. PERFORMANCE,31 Days,0.990110916,46408
Lower Gastrointestinal,Avg. PERFORMANCE,31 Days,0.984260574,30002
Lung,Avg. PERFORMANCE,31 Days,0.990341146,31111
Other,Avg. PERFORMANCE,31 Days,0.986117744,75554
Skin,Avg. PERFORMANCE,31 Days,0.97315643,46733
Urological,Avg. PERFORMANCE,31 Days,0.953419383,54341
ANTI-CANCER DRUG REGIMEN,Avg. PERFORMANCE,31 Days Sub (Drugs),0.995184563,91427
RADIOTHERAPY,Avg. PERFORMANCE,31 Days Sub (Radio),0.974304465,94343
SURGERY,Avg. PERFORMANCE,31 Days Sub (Surgery),0.958336966,54409
ALL CANCERS,Avg. PERFORMANCE,62 Days,0.810815121,145628
Breast,Avg. PERFORMANCE,62 Days,0.950613691,22852
Lower Gastrointestinal,Avg. PERFORMANCE,62 Days,0.716479818,14188
Lung,Avg. PERFORMANCE,62 Days,0.736836953,13271
Other,Avg. PERFORMANCE,62 Days,0.758047613,36117
Skin,Avg. PERFORMANCE,62 Days,0.926550982,28331
Urological (Excluding Testicular),Avg. PERFORMANCE,62 Days,0.732717346,33802
ALL CANCERS,Avg. PERFORMANCE,62 Days (Consultant),0.879873841,26624
ALL CANCERS,Avg. PERFORMANCE,62 Days (Screening),0.895478618,21055
Suspected urological malignancies (excluding testicular),TOTAL TREATED,2WW,0.943454075,201055
Suspected upper gastrointestinal cancer,TOTAL TREATED,2WW,0.924606541,189503
Suspected testicular cancer,TOTAL TREATED,2WW,0.972886443,10429
Suspected skin cancer,TOTAL TREATED,2WW,0.929837122,371805
Suspected sarcoma,TOTAL TREATED,2WW,0.941009995,10377
Suspected other cancer,TOTAL TREATED,2WW,0.948847496,2018
Suspected lung cancer,TOTAL TREATED,2WW,0.960406586,64451
Suspected lower gastrointestinal cancer,TOTAL TREATED,2WW,0.924925216,301455
Suspected head & neck cancer,TOTAL TREATED,2WW,0.952021689,176945
Suspected haematological malignancies (excluding acute leukaemia),TOTAL TREATED,2WW,0.960721769,17775
Suspected gynaecological cancer,TOTAL TREATED,2WW,0.953094997,170587
Suspected children's cancer,TOTAL TREATED,2WW,0.9543458,9361
Suspected breast cancer,TOTAL TREATED,2WW,0.942574039,331304
Suspected brain/central nervous system tumours,TOTAL TREATED,2WW,0.950691788,10055
Suspected acute leukaemia,TOTAL TREATED,2WW,0.962174941,183
Exhibited (non-cancer) breast symptoms - cancer not initially suspected,TOTAL TREATED,2WW Breast,0.92381584,209776
Urological,TOTAL TREATED,31 Days,0.953419383,54341
Skin,TOTAL TREATED,31 Days,0.97315643,46733
Other,TOTAL TREATED,31 Days,0.986117744,75554
Lung,TOTAL TREATED,31 Days,0.990341146,31111
Lower Gastrointestinal,TOTAL TREATED,31 Days,0.984260574,30002
Breast,TOTAL TREATED,31 Days,0.990110916,46408
ALL CANCERS,TOTAL TREATED,31 Days,0.978897299,284149
ANTI-CANCER DRUG REGIMEN,TOTAL TREATED,31 Days Sub (Drugs),0.995184563,91427
RADIOTHERAPY,TOTAL TREATED,31 Days Sub (Radio),0.974304465,94343
SURGERY,TOTAL TREATED,31 Days Sub (Surgery),0.958336966,54409
Urological (Excluding Testicular),TOTAL TREATED,62 Days,0.732717346,33802
Skin,TOTAL TREATED,62 Days,0.926550982,28331
Other,TOTAL TREATED,62 Days,0.758047613,36117
Lung,TOTAL TREATED,62 Days,0.736836953,13271
Lower Gastrointestinal,TOTAL TREATED,62 Days,0.716479818,14188
Breast,TOTAL TREATED,62 Days,0.950613691,22852
ALL CANCERS,TOTAL TREATED,62 Days,0.810815121,145628
ALL CANCERS,TOTAL TREATED,62 Days (Consultant),0.879873841,26624
ALL CANCERS,TOTAL TREATED,62 Days (Screening),0.895478618,21055